➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Dow
McKesson
McKinsey
Johnson and Johnson

Last Updated: August 5, 2020

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for bupivacaine hydrochloride

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Bulk Pharmaceutical API Sources for bupivacaine hydrochloride

Vendor Vendor Homepage Vendor Sku API Url
MP Biomedicals   Start Trial 154904   Start Trial
ISpharm   Start Trial I01-1868   Start Trial
MolPort   Start Trial MolPort-003-666-503   Start Trial
ABI Chem   Start Trial AC1L21TT   Start Trial
TimTec   Start Trial ST013772   Start Trial
ChemMol   Start Trial 49408190   Start Trial
ChemMol   Start Trial 49411753   Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
AstraZeneca
Mallinckrodt
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.